Skip to main content
OpenTrials

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

4,207 public trials 1,003 recruiting studies
Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Active, Not Recruiting

Multimodality Treatment in Stage III Non-small Cell Lung Cancer (NSCLC)

NCT04245514

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Universitätsklinikum Tübingen Tübingen, Germany
  • Kantonsspital Aarau Aarau, Switzerland
  • Kantonsspital Baden Baden, Switzerland
  • St. Claraspital Basel Basel, Switzerland
View all 13 locations
View Trial Details
Active, Not Recruiting

Pembrolizumab With or Without Anetumab Ravtansine in Treating Patients With Mesothelin-Positive Pleural Mesothelioma

NCT03126630

Conditions
Adenoma, Lung Diseases, Lung Neoplasms, +12 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
View all 33 locations
View Trial Details
Active, Not Recruiting

Crizotinib Continuation Clinical Study

NCT05160922

Conditions
ALCL, Bronchial Neoplasms, Carcinoma, Bronchogenic, +24 more
Locations
  • Cancer Hospital Chinese Academy of Medical Science Beijing, Beijing Municipality, China
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Fujian Province Oncology Hospital Fuzhou, Fujian, China
  • Sun Yat-Sen University Cancer center Guangzhou, Guangdong, China
View all 13 locations
View Trial Details
Active, Not Recruiting

TAK-788 as First-Line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion Mutations

NCT04129502

Conditions
Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC), Bronchial Neoplasms, Carcinoma, Bronchogenic, +8 more
Locations
  • City of Hope National Medical Center Long Beach, California, United States
  • University of California Irvine Orange, California, United States
  • Stanford University Palo Alto, California, United States
  • AdventHealth Orlando, Florida, United States
View all 134 locations
View Trial Details
Active, Not Recruiting

Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer

NCT03860272

Conditions
Adnexal Diseases, Advanced Cancer, Angiosarcoma, +42 more
Locations
  • HonorHealth Research Institute Scottsdale, Arizona, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • The Angeles Clinic & Research Institute, a Cedars-Sinai Affiliate Los Angeles, California, United States
  • University of Southern California Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 18 locations
View Trial Details

Related conditions